Share this

Protocol 005

Protocol 003: Immunogenicity of CAPVAXIVE™ vs PCV202
Protocol 006: Immunogenicity of CAPVAXIVE™ in adults previously vaccinated with other pneumococcal vaccinesc4
Protocol 010: Immunogenicity of CAPVAXIVE™ vs PPSV23b3
Protocol 005: Immunogenicity and safety of CAPVAXIVE™ when administered concomitantly with QIV⁵

AE-PCN-00050 | Expiry Date: 14-6-2028